• RCN2 Drives ESCC Metastasis and Cisplatin Resistance

  2026-08-28

  The reference study identifies RCN2 as a previously unrecognized driver of esophageal squamous cell carcinoma metastasis and cisplatin resistance. Its mechanistic model connects RCN2 to UBR5-dependent PPP2CA degradation and subsequent PI3K-AKT pathway activation, suggesting a rationale for combining RCN2-directed strategies with cisplatin.

• LY2603618: A Personalized DDR Assay Framework

  2026-08-28

  LY2603618 is a selective Chk1 inhibitor for dissecting DNA damage, checkpoint failure, and chemotherapy sensitization. This article connects its oncology applications with an iPSC-based prescreening concept to show how model choice and multidimensional readouts can improve assay interpretation.

• HNF4A-AS1 and Sorafenib Resistance in HCC

  2026-08-27

  A 2024 Theranostics study identifies the liver-enriched lncRNA HNF4A-AS1 as a regulator of sorafenib-induced ferroptosis in hepatocellular carcinoma. Its loss increases DECR1 expression, reduces intracellular polyunsaturated fatty acids, and enables drug resistance, linking RNA modification to lipid metabolic reprogramming.

• CNO: From Inert Ligand to Circuit Control

  2026-08-27

  Clozapine N-oxide has evolved from a pharmacologically quiet clozapine metabolite into a powerful chemogenetic actuator. This thought-leadership guide connects the molecular logic of DREADDs with experimental controls, translational strategy, and practical reagent considerations.

• Plk1 Control of p31comet in Mitotic Checkpoint Exit

  2026-08-26

  The reference study shows that Polo-like kinase 1 (Plk1) restrains p31comet- and TRIP13-dependent disassembly of mitotic checkpoint complexes by phosphorylating p31comet at Ser102. This mechanism helps prevent premature checkpoint silencing and provides a biochemical explanation for how active mitosis avoids a futile cycle of checkpoint complex assembly and disassembly.

• Mitochondrial Repair in Diabetic Periodontitis

  2026-08-26

  The reference study develops a hierarchically targeted, ROS-responsive hydrogel that delivers MitoQ to dysfunctional mitochondria in M1 macrophages. Its results connect mitochondrial repair with reduced NLRP3 inflammasome activity, improved osteogenic signaling, and enhanced periodontal bone regeneration in a diabetic periodontitis rat model.

• Tricine-SDS-PAGE Gel Preparation Kit Guide

  2026-08-25

  The Tricine-SDS-PAGE Gel Preparation Kit is intended for high-resolution separation of low-molecular-weight proteins and peptides that may be poorly resolved by conventional Tris-SDS-PAGE. It is suitable for research workflows using denaturing or, when all reagents are compatible, non-denaturing electrophoresis, but it is not intended for diagnostic or medical use.

• JZL184 Workflows for CB1–GLT-1 Research

  2026-08-25

  JZL184 provides an upstream way to manipulate 2-AG turnover and test how MAGL–CB1 signaling affects astrocytic GLT-1, neuronal survival, and behavior. This practical guide connects TBI experiments with synaptic, pain, and affective research while emphasizing controls, timing, and formulation quality.

• A Polyvalent Vaccine Targets Tumor-Associated Bacteria

  2026-08-24

  Kang and colleagues developed a polyvalent vaccine that combines soluble and insoluble antigens from tumor-associated bacteria to target microbes implicated in breast cancer metastasis. In bacteria-induced mouse models, vaccination promoted bacterial elimination and reduced metastatic progression, supporting tumor microbiome modulation as a potential anticancer strategy.

• Ribociclib and Acid-Reducing Agents: QbD Evidence

  2026-08-24

  This study applies an Analytical Quality by Design workflow and biorelevant micro-dissolution model to examine whether gastric pH shifts alter ribociclib succinate behavior. Although solubility decreased after simulated gastric-to-intestinal transitions, the authors concluded that the changes were unlikely to produce a significant absorption interaction with acid-reducing agents under the tested conditions.

• Bismuth Subsalicylate: A Translational GI Map

  2026-08-23

  Bismuth Subsalicylate can serve as more than a symptom-oriented research reagent: it is a mechanistically anchored perturbation tool for gastrointestinal disorder research. This article connects prostaglandin G/H synthase inhibition with assay strategy, membrane biology, apoptosis validation, and translational decision-making while clearly separating established evidence from exploratory applications.

• Sulfo-NHS-LC-Biotin: Practical Labeling Guide

  2026-08-22

  Sulfo-NHS-LC-Biotin is a water-soluble reagent for stable biotin labeling of accessible primary amines on proteins, peptides, and intact cell-surface proteins. It is suited to streptavidin-based detection or capture, but not to intracellular labeling in intact cells or workflows requiring reversible modification.

• Rifampin as a Precision Transcriptional Benchmark

  2026-08-22

  Rifampin is more than a rifamycin antibiotic: it is a powerful layer-specific benchmark for separating bacterial transcriptional effects from translational control. This article connects Rifampin mechanism, assay design, resistance research, and insights from a 2026 optogenetic gene-regulation study.

• Ceftolozane/Tazobactam: Evidence and Research Implications

  2026-08-21

  The reference review presents ceftolozane/tazobactam as an antipseudomonal cephalosporin/β-lactamase inhibitor combination designed to address resistant Gram-negative pathogens, especially Pseudomonas aeruginosa and selected ESBL-producing Enterobacteriaceae. Its most important translational contributions are the linkage of PBP3-directed activity, β-lactamase inhibition, and time-dependent pharmacodynamics with clinical dosing and renal-function considerations.

• Patient-Derived Gastric Cancer Assembloids

  2026-08-20

  Shapira-Netanelov and colleagues developed patient-matched gastric cancer assembloids that combine tumor organoids with stromal subpopulations derived from the same tissue. The model captures tumor–stroma effects on gene expression and drug sensitivity, providing a more physiologically informative platform for resistance studies and personalized therapeutic testing.

8069 records 1/538 page Next 12345 下5页 Last page